UCB
REGN icon

United Community Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

United Community Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Sell
23
-25
-52% -$17K ﹤0.01% 419
2026
Q1 		$37.1K Sell
48
-5
-9% -$3.83K 0.01% 367
2025
Q4 		$40.9K Sell
53
-121
-70% -$82.2K 0.02% 309
2025
Q3 		$97.8K Buy
174
+8
+5% +$4.52K 0.03% 270
2025
Q2 		$87.2K Buy
166
+50
+43% +$27.9K 0.03% 265
2025
Q1 		$73.6K Buy
116
+20
+21% +$13.8K 0.03% 284
2024
Q4 		$68.4K Hold
96
– – 0.03% 280
2024
Q3 		$101K Sell
96
-29
-23% -$32.3K 0.04% 247
2024
Q2 		$131K Hold
125
– – 0.05% 229
2024
Q1 		$120K Sell
125
-5
-4% -$4.75K 0.05% 229
2023
Q4 		$114K Hold
130
– – 0.05% 234
2023
Q3 		$107K Buy
130
+15
+13% +$11.8K 0.05% 209
2023
Q2 		$82.6K Buy
115
+10
+10% +$7.71K 0.07% 156
2023
Q1 		$86.3K Hold
105
– – 0.08% 131
2022
Q4 		$75.8K Sell
105
-25
-19% -$18.4K 0.07% 144
2022
Q3 		$89.6K Buy
130
+40
+44% +$25.2K 0.09% 122
2022
Q2 		$53.2K Sell
90
-10
-10% -$6.5K 0.06% 159
2022
Q1 		$69.8K Hold
100
– – 0.07% 148
2021
Q4 		$63.2K Buy
+100
New +$61.5K 0.06% 153

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

United Community Bank's REGN Position: Q2 2026 in Review

United Community Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 52% in Q2 2026, selling an estimated $17K and leaving 23 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

United Community Bank first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $131K in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • United Community Bank held 23 shares of Regeneron Pharmaceuticals worth $14.3K as of Q2 2026.
  • United Community Bank sold 25 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $17K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of United Community Bank's portfolio in Q2 2026, its #419 holding.
  • United Community Bank first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • United Community Bank's Regeneron Pharmaceuticals position peaked at $131K in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on United Community Bank's 13F filing for Q2 2026, filed 13 Aug 2026.